Fingerprint
Dive into the research topics of 'In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
Mariam M. AlHilli, Marc A. Becker, S. John Weroha, Karen S. Flatten, Rachel M. Hurley, Maria I. Harrell, Ann L. Oberg, Matt J. Maurer, Kieran M. Hawthorne, Xiaonan Hou, Sean C. Harrington, Sarah McKinstry, X. Wei Meng, Keith M. Wilcoxen, Kimberly R. Kalli, Elizabeth M. Swisher, Scott H. Kaufmann, Paul Haluska
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations